216 related articles for article (PubMed ID: 30409840)
1. Apocrine lesions of the breast: part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast.
D'Arcy C; Quinn C
J Clin Pathol; 2019 Jan; 72(1):1-6. PubMed ID: 30409840
[TBL] [Abstract][Full Text] [Related]
2. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
Tramm T; Kim JY; Tavassoli FA
Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
[TBL] [Abstract][Full Text] [Related]
3. Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast.
D'Arcy C; Quinn CM
J Clin Pathol; 2019 Jan; 72(1):7-11. PubMed ID: 30425121
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostics of benign ductal epithelial cell proliferation of the breast in biopsy material].
Sinn HP; Flechtenmacher C; Aulmann S
Pathologe; 2014 Feb; 35(1):18-25. PubMed ID: 24448666
[TBL] [Abstract][Full Text] [Related]
5. Mixed pleomorphic lobular and apocrine carcinoma of the breast: A case report suggesting pathogenesis.
Ishii A; Oishi T; Kakuda Y; Yasui H; Kawata T; Muramatsu K; Takahashi K; Sugino T
Pathol Int; 2019 May; 69(5):288-293. PubMed ID: 30811750
[TBL] [Abstract][Full Text] [Related]
6. Apocrine lesions of the breast.
Quinn CM; D'Arcy C; Wells C
Virchows Arch; 2022 Jan; 480(1):177-189. PubMed ID: 34537861
[TBL] [Abstract][Full Text] [Related]
7. Apocrine carcinoma vs. apocrine metaplasia with atypia of the breast. Use of aspiration biopsy cytology.
Yoshida K; Inoue M; Furuta S; Sakai R; Imai R; Hayakawa S; Fukatsu T; Nagasaka T; Nakashima N
Acta Cytol; 1996; 40(2):247-51. PubMed ID: 8629406
[TBL] [Abstract][Full Text] [Related]
8. The histologic spectrum of apocrine breast proliferations: a comparative study of morphology and DNA content by image analysis.
Raju U; Zarbo RJ; Kubus J; Schultz DS
Hum Pathol; 1993 Feb; 24(2):173-81. PubMed ID: 8381766
[TBL] [Abstract][Full Text] [Related]
9. The Histologic Spectrum of Apocrine Lesions of the Breast.
Durham JR; Fechner RE
Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of apocrine lesions of the breast.
O'Malley FP; Bane AL
Adv Anat Pathol; 2004 Jan; 11(1):1-9. PubMed ID: 14676636
[TBL] [Abstract][Full Text] [Related]
11. Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions.
Purcell CA; Norris HJ
Ann Diagn Pathol; 1998 Apr; 2(2):135-45. PubMed ID: 9845731
[TBL] [Abstract][Full Text] [Related]
12. The challenge of apocrine proliferations of the breast: a morphologic approach.
Masood S; Rosa M
Pathol Res Pract; 2009; 205(3):155-64. PubMed ID: 19147303
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions.
Vougiouklakis T; Belovarac BJ; Lytle A; Chiriboga L; Ozerdem U
Pathol Res Pract; 2020 Sep; 216(9):153041. PubMed ID: 32825929
[TBL] [Abstract][Full Text] [Related]
15. Cytology of pleomorphic lobular carcinoma with apocrine cell differentiation of the breast. A case report.
Tashiro T; Hirokawa M; Iuchi K; Emoto K; Tanaka T; Monobe Y; Sano T
Acta Cytol; 2003; 47(2):265-9. PubMed ID: 12685199
[TBL] [Abstract][Full Text] [Related]
16. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
Kővári B; Báthori Á; Cserni G
Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
[TBL] [Abstract][Full Text] [Related]
17. Apocrine differentiation in invasive pleomorphic lobular carcinoma with in situ ductal and lobular apocrine carcinoma: case report.
Kaya H; Aribal E; Yegen C
Pathol Oncol Res; 2002; 8(2):151-2. PubMed ID: 12172583
[TBL] [Abstract][Full Text] [Related]
18. Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case.
Visscher DW
Arch Pathol Lab Med; 2009 Nov; 133(11):1817-21. PubMed ID: 19886717
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic pitfalls in mammary pathology. Case 2. Atypical duct hyperplasia within columnar cell changes with atypia].
Vincent-Salomon A
Ann Pathol; 2009 Jun; 29(3):194-8. PubMed ID: 19619825
[No Abstract] [Full Text] [Related]
20. [Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].
Yang G; Guo L; Jin H; Li J; Ding H
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):437-41. PubMed ID: 25327790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
